GR3022011T3 - Inhibition of padgem-mediated cell binding - Google Patents

Inhibition of padgem-mediated cell binding

Info

Publication number
GR3022011T3
GR3022011T3 GR960403237T GR960403237T GR3022011T3 GR 3022011 T3 GR3022011 T3 GR 3022011T3 GR 960403237 T GR960403237 T GR 960403237T GR 960403237 T GR960403237 T GR 960403237T GR 3022011 T3 GR3022011 T3 GR 3022011T3
Authority
GR
Greece
Prior art keywords
padgem
inhibition
cell binding
mediated cell
cell
Prior art date
Application number
GR960403237T
Other languages
English (en)
Inventor
Bruce Furie
Eric Larsen
Alessandro Celi
Gary E Gilbert
Barbara C Furie
John K Erban
Roberta Bonfanti
Denisa D Wagner
Original Assignee
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Medical Center Inc filed Critical New England Medical Center Inc
Publication of GR3022011T3 publication Critical patent/GR3022011T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Networks Using Active Elements (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GR960403237T 1989-10-20 1996-12-12 Inhibition of padgem-mediated cell binding GR3022011T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42488689A 1989-10-20 1989-10-20
PCT/US1990/006101 WO1991006632A1 (en) 1989-10-20 1990-10-22 Inhibition of padgem-mediated cell binding

Publications (1)

Publication Number Publication Date
GR3022011T3 true GR3022011T3 (en) 1997-03-31

Family

ID=23684279

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960403237T GR3022011T3 (en) 1989-10-20 1996-12-12 Inhibition of padgem-mediated cell binding

Country Status (9)

Country Link
EP (1) EP0496832B1 (el)
JP (1) JPH05504470A (el)
AT (1) ATE146218T1 (el)
CA (1) CA2067250C (el)
DE (1) DE69029398T2 (el)
DK (1) DK0496832T3 (el)
ES (1) ES2097765T3 (el)
GR (1) GR3022011T3 (el)
WO (1) WO1991006632A1 (el)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021956A1 (en) * 1992-05-05 1993-11-11 Cytel Corporation Antibodies to p-selectin and their uses
US5800815A (en) * 1903-05-05 1998-09-01 Cytel Corporation Antibodies to P-selectin and their uses
US5464778A (en) * 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US5753631A (en) * 1990-06-15 1998-05-19 Cytel Corporation Intercellular adhesion mediators
ATE224911T1 (de) * 1990-07-17 2002-10-15 Univ Oklahoma Gmp-140 ligand
US6309639B1 (en) 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US6124267A (en) * 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US5807745A (en) * 1991-03-11 1998-09-15 New England Medical Center Hospitals, Inc. Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core component
CA2105997A1 (en) * 1991-03-11 1992-09-12 Bruce Furie Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component
CA2110495A1 (en) * 1991-06-10 1992-12-23 Robert M. Ippolito Immunosuppressive and tolerogenic oligosaccharide derivatives
US5646123A (en) * 1991-06-10 1997-07-08 Alberta Research Council Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen
JPH07507040A (ja) * 1991-09-10 1995-08-03 セントコー，インコーポレイテッド セレクチンによって介在される炎症のペプチド阻害剤
CA2120240A1 (en) * 1991-09-30 1993-03-31 Theresa M. Palabrica Inhibition of vascular narrowing using anti-padgen antibodies
JPH07501828A (ja) * 1991-12-18 1995-02-23 セントコー，インコーポレイテッド セレクチン類で仲介される炎症のペプチド阻害剤
US6033667A (en) * 1992-05-05 2000-03-07 Cytel Corporation Method for detecting the presence of P-selectin
EP0731709B1 (en) * 1992-05-11 2001-10-24 Corvas International, Inc. Neutrophil inhibitors from nematodes
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
US6277975B1 (en) 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
ATE256182T1 (de) * 1992-10-23 2003-12-15 Inst Genetics Llc Neuartiges p- selectin ligandenprotein
WO1994011498A1 (en) * 1992-11-16 1994-05-26 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for p-selectin and methods of use thereof
EP0804235A4 (en) * 1993-05-04 2001-09-19 Aeres Biomedical Ltd ANTIBODIES AGAINST SELECTIN P AND USES THEREOF
AU2361395A (en) * 1994-04-28 1995-11-29 Genetics Institute Inc. Novel P-selectin ligand protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88308A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides that block the binding of von willebrand factor
ATE224911T1 (de) * 1990-07-17 2002-10-15 Univ Oklahoma Gmp-140 ligand

Also Published As

Publication number Publication date
CA2067250A1 (en) 1991-04-21
ATE146218T1 (de) 1996-12-15
EP0496832A4 (en) 1993-02-17
EP0496832A1 (en) 1992-08-05
DE69029398T2 (de) 1997-04-10
EP0496832B1 (en) 1996-12-11
CA2067250C (en) 2008-06-17
DE69029398D1 (de) 1997-01-23
WO1991006632A1 (en) 1991-05-16
ES2097765T3 (es) 1997-04-16
DK0496832T3 (da) 1996-12-30
JPH05504470A (ja) 1993-07-15

Similar Documents

Publication Publication Date Title
GR3022011T3 (en) Inhibition of padgem-mediated cell binding
DE68909428T2 (de) Filteranlage für Proben.
DE69014507T2 (de) Gerät zur Zellenvorbehandlung für Durchfluss-Zytometrie.
DE3671105D1 (de) Automatischer analysator mit freiem zugang zur probe.
AU4827990A (en) Apparatus and method for sequential determination of an analyte in a fluid sample
EP0628822A3 (en) Automatic blood analysis system.
EP0226767A3 (en) Transparent test-strip system
EP0299517A3 (en) Long-test-film cassette for biochemical analysis, and system for loading the same
EP0571053A3 (en) Analytical method and device for biological specimen.
AU8058798A (en) Method and device for detecting or quantifying carbohydrate containing compounds
EP0637750A3 (de) Verfahren zur Analyse von Probenflüssigkeiten.
DE68923389T2 (de) Detektorzelle für Flüssigkeitschromatographie.
ES8704004A1 (es) Un metodo de ensayo de fijacion especifico para determinar un ligando en una muestra
ES551760A0 (es) Un metodo cromatografico de afinidad para la determinacion de antigenos en liquidos biologicos.
AU2445488A (en) Injection systems for sample testing for luminometers
ES511797A0 (es) "metodo para ensayar reacciones antigeno-anticuerpo".
NO890867L (no) Fluidum-proevetaker, saerlig for benyttelse i en oljebroenn.
NO864113D0 (no) Fremgangsmaate for immonoassay, samt analysesett for dens utfoerelse.
AU8917291A (en) Method for quantitatively assaying the presence fo diarrhetic shellfish poisoning toxins in marine samples.
EP0623819A3 (en) Device for determining the concentration of various ions in aqueous solutions.
NO910202L (no) Fremgangsmaate for aa identifisere hydrokarbonfoerende lag iundergrunnsformasjoner.
DE3569941D1 (en) Reagent for assaying creatine kinase
CA2344193A1 (en) Cobalamin assay
DE69021912D1 (de) Probeneinspritzzelle.
DE3269480D1 (en) Device for measuring an ion concentration, and its application to ph determination